These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1811657)

  • 1. [Influence of exogenous factors on the behavior of aminophenazone breath test in chronic liver diseases].
    Treutler J; Sensing H; Haustein KO; Hüller G
    Gastroenterol J; 1991; 51(3-4):132-5. PubMed ID: 1811657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavior of the aminophenazone breath test in chronic liver diseases].
    Treutler J; Sensing H; Haustein KO; Hüller G
    Z Gesamte Inn Med; 1988 Dec; 43(23):688-92. PubMed ID: 3245251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The diagnostic value of the aminophenazone breath test in chronic liver diseases].
    Sensing H; Treutler J; Haustein KO; Hüller G
    Z Gesamte Inn Med; 1991 Sep; 46(13):478-82. PubMed ID: 1962492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on diagnostic and prognostic validity of aminophenazone breath test in liver cirrhosis].
    Sensing H; Treutler J; Haustein KO; Hüller G
    Gastroenterol J; 1991; 51(3-4):112-6. PubMed ID: 1811653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic relevance of the aminopyrine breath test in liver disease].
    Wildgrube HJ; Stang H
    Z Gastroenterol; 1982 Nov; 20(11):667-72. PubMed ID: 7180067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 13CO2 excretion in breath of normal subjects and cirrhotic patients after 13C-aminopyrine oral load. Comparison with MEGX test in functional differentiation between chronic hepatitis and liver cirrhosis.
    Fasoli A; Giannini E; Botta F; Romagnoli P; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(31):234-8. PubMed ID: 10690614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for routine determination of the metabolic liver capacity: the aminopyrine breath test.
    Haustein KO; Schenker E
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23(4):190-6. PubMed ID: 3922902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic value of antithrombin III and aminopyrine breath test in liver disease.
    Rodzynek JJ; Preux C; Leautaud P; Abramovici J; Di Paolo A; Delcourt AA
    Arch Intern Med; 1986 Apr; 146(4):677-80. PubMed ID: 3963948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between aminopyrine breath test and severity of liver disease in cirrhosis.
    Morelli A; Narducci F; Pelli MA; Farroni F; Vedovelli A
    Am J Gastroenterol; 1981 Aug; 76(2):110-3. PubMed ID: 6795921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Quantification of the drug-metabolizing enzyme system in liver diseases: a comparison between antipyrine saliva clearance and the aminopyrine breath test].
    von Mandach U; Jost G; Preisig R
    Schweiz Med Wochenschr; 1985 May; 115(19):651-8. PubMed ID: 3923620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences with the 14C-aminopyrine breath test in liver cirrhosis and under the effect of sodium diclofenac (Voltaren)].
    Reinicke C; Eitner K; Hippius M; Krombholz B; Stiller KJ; Wächter G
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(3):117-29. PubMed ID: 6603964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of liver function by the aminopyrine breath test.
    Villeneuve JP; Arsène D; Huet PM
    Clin Invest Med; 1983; 6(1):5-9. PubMed ID: 6403268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminopyrine breath test: development of a 13C-breath test for quantitative assessment of liver function in humans.
    Mion F; Queneau PE; Rousseau M; Brazier JL; Paliard P; Minaire Y
    Hepatogastroenterology; 1995; 42(6):931-8. PubMed ID: 8847048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test.
    Saunders JB; Lewis KO; Paton A
    Gastroenterology; 1980 Jul; 79(1):112-4. PubMed ID: 6769747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies of dialysis patients using the 14C aminophenazone breath test].
    Heinrich HG; Mayer WK; Adler D; Hornak H; Wünschmann HJ
    Gastroenterol J; 1989; 49(2):76-8. PubMed ID: 2803531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease.
    Schneider JF; Baker AL; Haines NW; Hatfield G; Boyer JL
    Gastroenterology; 1980 Dec; 79(6):1145-50. PubMed ID: 6777231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired hepatic mitochondrial oxidation using the 13C-methionine breath test in patients with macrovesicular steatosis and patients with cirrhosis.
    Spahr L; Negro F; Leandro G; Marinescu O; Goodman KJ; Rubbia-Brandt L; Jordan M; Hadengue A
    Med Sci Monit; 2003 Jan; 9(1):CR6-11. PubMed ID: 12552242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative liver function tests as surrogate markers for end-points in controlled clinical trials: a retrospective feasibility study.
    Lotterer E; Högel J; Gaus W; Fleig WE; Bircher J
    Hepatology; 1997 Dec; 26(6):1426-33. PubMed ID: 9397982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 13C-methacetin breath test as liver function test in patients with chronic hepatitis C virus infection.
    Braden B; Faust D; Sarrazin U; Zeuzem S; Dietrich CF; Caspary WF; Sarrazin C
    Aliment Pharmacol Ther; 2005 Jan; 21(2):179-85. PubMed ID: 15679768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.